Search Results

You are looking at 231 - 240 of 1,296 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Baijun Dong, Liancheng Fan, Bin Yang, Wei Chen, Yonghong Li, Kaijie Wu, Fengbo Zhang, Haiying Dong, Huihua Cheng, Jiahua Pan, Yinjie Zhu, Chenfei Chi, Liang Dong, Jianjun Sha, Lei Li, Xudong Yao, and Wei Xue

subsequent multivariate analyses. A test result was considered as statistically significant for P <.05. Results Patient Characteristics From the 8 institutions, 292 patients were recruited for analysis between December 2017 and December 2019

Full access

Ayal A. Aizer, Jonathan J. Paly, Anthony L. Zietman, Paul L. Nguyen, Clair J. Beard, Sandhya K. Rao, Irving D. Kaplan, Andrzej Niemierko, Michelle S. Hirsch, Chin-Lee Wu, Aria F. Olumi, M. Dror Michaelson, Anthony V. D’Amico, and Jason A. Efstathiou

androgen deprivation therapy, or a combination of any of these therapies. Statistical Methodology Continuous baseline patient characteristics were compared with either the 2 sample t test or a nonparametric k-sample test on the equality of medians

Full access

Siew Tzuh Tang, Jen-Shi Chen, Fur-Hsing Wen, Wen-Chi Chou, John Wen-Cheng Chang, Chia-Hsun Hsieh, and Chen Hsiu Chen

eAppendix 4 ). Data Collection Participants’ characteristics were assessed at baseline (before random assignment). Data on outcome measures (LST preferences, QoL, anxiety symptoms, and depressive symptoms) and time-varying covariates were collected at

Full access

Katrine Løppenthin, Christoffer Johansen, Matilde Bille Larsen, Birgitte Hysse Forchhammer, Jannick Brennum, Karin Piil, Neil Aaronson, Birthe Krogh Rasmussen, and Pernille Bidstrup

refused to participate or for whom data were missing ( supplemental eTable 1 , available with this article at JNCCN.org ). Study Cohort Characteristics Characteristics of the study samples are presented in Table 1 . Men represented 60% of the

Full access

Leslie R. Schover, Ying Yuan, Bryan M. Fellman, Evan Odensky, Pamela E. Lewis, and Paul Martinetti

professionals provided counseling and were supervised weekly by the first author (LRS). Counselors guided women through the Web site and discussed behavioral homework. Statistical Analyses Demographic and clinical characteristics were summarized with

Full access

Ju Dong Yang, Michael Luu, Amit G. Singal, Mazen Noureddin, Alexander Kuo, Walid S. Ayoub, Vinay Sundaram, Honore Kotler, Irene K. Kim, Tsuyoshi Todo, Georgios Voidonikolas, Todd V. Brennan, Kambiz Kosari, Andrew S. Klein, Andrew Hendifar, Shelly C. Lu, Nicholas N. Nissen, and Jun Gong

For patients who received multiple courses of treatments, the most invasive surgical procedure for the primary site (liver transplantation > resection > ablation) was reported in the database. Statistical Analysis Baseline characteristics in patients

Full access

Mohammad Abu Zaid, Paul C. Dinh Jr, Patrick O. Monahan, Chunkit Fung, Omar El-Charif, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Clair J. Beard, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Howard D. Sesso, Robert Huddart, Taisei Mushiroda, Michiaki Kubo, M. Eileen Dolan, Lawrence H. Einhorn, Sophie D. Fossa, Lois B. Travis, and for the Platinum Study Group

Platinum Study ( P =.30), and other clinical and sociodemographic characteristics ( supplemental eTable 1 , available with this article at JNCCN.org ). Data on the prevalence of metabolic syndrome and its risk factors in this cohort have been previously

Full access

Christopher J. Magnani, Kevin Li, Tina Seto, Kathryn M. McDonald, Douglas W. Blayney, James D. Brooks, and Tina Hernandez-Boussard

. Characteristics of Patients Eligible for Screening In the OptumLabs 1% sample, we identified 93,334 prepolicy and 110,067 postpolicy patients. Patient counts for the control and exposure groups were equivalent for the OptumLabs analysis because patient records

Full access

Richard Li, Ashwin Shinde, Marwan Fakih, Stephen Sentovich, Kurt Melstrom, Rebecca Nelson, Scott Glaser, Yi-Jen Chen, Karyn Goodman, and Arya Amini

in the final matched cohort. All statistical analyses were performed using SPSS Statistics, version 23 (IBM Corp.). Results Patient Cohort Characteristics A total of 3,729 patients with a median follow-up of 41.1 months who met the inclusion criteria

Full access

Taymeyah Al-Toubah, Eleonora Pelle, Tiffany Valone, Mintallah Haider, and Jonathan R. Strosberg

correlations and chi-square analyses. Results Patient Characteristics Supplemental eTable 1 presents patient demographics (available with this article at JNCCN.org ), and Table 1 presents tumor characteristics. A total of 462 patients met